• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: INSULET CORPORATION OMNIPOD INSULIN MANAGEMENT SYSTEM; PUMP, INFUSION, INSULIN

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

INSULET CORPORATION OMNIPOD INSULIN MANAGEMENT SYSTEM; PUMP, INFUSION, INSULIN Back to Search Results
Model Number 18900-5A
Medical Device Problem Code Failure to Power Up (1476)
Health Effect - Clinical Codes Hyperglycemia (1905); Elevated ketones/Diabetic Ketoacidosis (2364)
Date of Event 07/06/2023
Type of Reportable Event Serious Injury
Event or Problem Description
It was reported that the patient was hospitalized due to diabetic ketoacidosis (dka) and high blood glucose (bg) levels of 206 mg/dl.The patient's omnipod personal diabetes manager (pdm) could not be turned on, which led to the event.At the hospital, the patient was administered fluids.
 
Additional Manufacturer Narrative
We are unable to determine if any product condition could have contributed to the reported hospitalization and diabetic ketoacidosis.Lot release records were reviewed and the product lot met all acceptance criteria.Specifically, a pod is paired to a pdm and put through simulated use testing including communicating with the pdm, deployment, delivering fluid, occlusion detection, and freedom from hazard alarms."high blood glucose is a common symptom for people with diabetes (glucose monitoring data from people with diabetes indicate that on average, they can experience blood glucose levels above 250 mg/dl for 14-25% of the time[1][2][3]), and it would be challenging to speculate on a cause for the complaints without receiving the devices back for an engineering investigation.[1] beck rw, bergenstal rm, cheng p, kollman c, carlson al, johnson ml, rodbard d.The relationships between time in range, hyperglycemia metrics, and hba1c.J diabetes sci technol 2019;13:614-626.[1] welsh jb, derdzinski m, parker as, puhr s, jimenez a, walker t.Real-time sharing and following of continuous glucose monitoring data in youth.Diabetes ther 2019;10:751-755.[1] puhr s, derdzinski m, welsh jb, parker as, walker t, price da.Real-world hypoglycemia avoidance with a continuous glucose monitoring system's predictive low glucose alert.Diabetes technol ther 2019;21:155-158".
 
Additional Manufacturer Narrative
In the case description, the patient states the device did not turn on and they had no way to inject insulin.The device was returned for investigation.The batteries were not returned with the device.Upon connecting different batteries, the device powered on.After the device went past the home screen, the device began to alarm and displayed a pdm alarm on the screen.The device was reset.Upon reset, the device got to the home screen as intended.The device data was downloaded.Inspection of the device data shows that the device generated an alarm on the date of occurrence.This alarm was the same alarm that was displayed upon initially powering on the device.It could not conclusively be determined if this alarm contributed to the reported event.Inspection of the device interior found no damages or deficiencies that would cause the device to be unable to power on.Based on the investigation, the device functioned as intended.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
OMNIPOD INSULIN MANAGEMENT SYSTEM
Common Device Name
PUMP, INFUSION, INSULIN
Manufacturer (Section D)
INSULET CORPORATION
100 nagog park
acton MA 01720
Manufacturer (Section G)
INSULET CORPORATION
100 nagog park
acton MA 01720
Manufacturer Contact
thom mcnamara
100 nagog park
acton, MA 01720
9786007000
MDR Report Key17289969
Report Number3004464228-2023-17316
Device Sequence Number5510413
Product Code LZG
UDI-Device Identifier10385081120012
UDI-Public(01)10385081120012(11)201219(10)L61314
Combination Product (Y/N)N
Initial Reporter StateMA
Initial Reporter CountryUS
PMA/510(K) Number
K211575
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source Foreign,Consumer
Initial Reporter Occupation Other
Type of Report Initial,Followup
Report Date (Section B) 07/06/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Lay User/Patient
Device Model Number18900-5A
Device Catalogue NumberPDM-UST400
Device Lot NumberL61314
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? No
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 07/06/2023
Supplement Date Received by Manufacturer09/19/2023
Initial Report FDA Received Date07/10/2023
Supplement Report FDA Received Date09/20/2023
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured12/19/2020
Is the Device Labeled for Single Use? (Y/N) No
Usage of Device Reuse
Patient Sequence Number1
Outcome Attributed to Adverse Event Hospitalization; Required Intervention;
Patient SexUnknown
-
-